Veeraraghavan, H.; Vargas, H.A.; Jimenez-Sanchez, A.; Micco, M.; Mema, E.; Lakhman, Y.; Crispin-Ortuzar, M.; Huang, E.P.; Levine, D.A.; Grisham, R.N.;
et al. Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma. Cancers 2020, 12, 3403.
https://doi.org/10.3390/cancers12113403
AMA Style
Veeraraghavan H, Vargas HA, Jimenez-Sanchez A, Micco M, Mema E, Lakhman Y, Crispin-Ortuzar M, Huang EP, Levine DA, Grisham RN,
et al. Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma. Cancers. 2020; 12(11):3403.
https://doi.org/10.3390/cancers12113403
Chicago/Turabian Style
Veeraraghavan, Harini, Herbert Alberto Vargas, Alejandro Jimenez-Sanchez, Maura Micco, Eralda Mema, Yulia Lakhman, Mireia Crispin-Ortuzar, Erich P. Huang, Douglas A. Levine, Rachel N. Grisham,
and et al. 2020. "Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma" Cancers 12, no. 11: 3403.
https://doi.org/10.3390/cancers12113403
APA Style
Veeraraghavan, H., Vargas, H. A., Jimenez-Sanchez, A., Micco, M., Mema, E., Lakhman, Y., Crispin-Ortuzar, M., Huang, E. P., Levine, D. A., Grisham, R. N., Abu-Rustum, N., Deasy, J. O., Snyder, A., Miller, M. L., Brenton, J. D., & Sala, E.
(2020). Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma. Cancers, 12(11), 3403.
https://doi.org/10.3390/cancers12113403